Researchers are studying the effects of metformin -- approved in 1958 to treat diabetes -- on breast, ovarian, colon, prostate and other cancers. The drug is safe and cheap, and it appears to improve survival in pancreatic cancer patients, says Donghui Li, an epidemiologist and professor of medicine at The University of Texas MD Anderson Cancer Center.